Search research articles
Contact Us
Filters
Showing results (51-60 of 86) with videos related to
Page
of 9
Sort By:
Life Sciences
|
September 15, 1975
Increase in rat brain acetylcholine induced by choline or deanol
D R Haubrich, P F Wang, D E Clody, et al.
European Journal of Pharmacology
|
September 1, 1975
Increased susceptibility to seizures and decreased catecholamine turnover in spontaneously hypertensive rats
M E Goldberg, J E Milmore, M K Haubrich, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1990
Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro
M H Perrone, L T Hamel, R A Ferrari, et al.
Antiviral Therapy
|
February 22, 2000
Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm3
D A Revicki, C Swartz, A W Wu, et al.
Human Gene Therapy
|
July 1, 1995
An open label, phase I/II clinical trial to evaluate the safety and biological activity of HIV-IT (V) (HIV-1IIIBenv/rev retroviral vector) in HIV-1-infected subjects
R Haubrich, J A McCutchan, R Holdredge, et al.
Annals of the New York Academy of Sciences
|
November 27, 1995
Retroviral vectors for HIV immunotherapy
J F Warner, D Jolly, S Mento, et al.
Journal of Medicinal Chemistry
|
February 1, 1982
Aminomethyl-1,2,4-benzothiadiazines as potential analogues of gamma-aminobutyric acid. Unexpected discovery of a taurine antagonist
Y Girard, J G Atkinson, D R Haubrich, et al.
The Western Journal of Medicine
|
August 5, 2000
From the cell to the community: AIDS research in California. The University of California Universitywide AIDS Research Program annual meeting, February 2000
N E Moss, G Lemp, R Bluthenthal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 4, 2011
Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting
G U van Zyl, W Preiser, S Potschka, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1990
In vivo assessment of napamezole, an alpha-2 adrenoceptor antagonist and monoamine re-uptake inhibitor
M H Perrone, D Luttinger, L T Hamel, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 86) with videos related to
Sort By:
Page
of 9
Life Sciences
|
September 15, 1975
Increase in rat brain acetylcholine induced by choline or deanol
D R Haubrich, P F Wang, D E Clody, et al.
European Journal of Pharmacology
|
September 1, 1975
Increased susceptibility to seizures and decreased catecholamine turnover in spontaneously hypertensive rats
M E Goldberg, J E Milmore, M K Haubrich, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1990
Napamezole, an alpha-2 adrenergic receptor antagonist and monoamine uptake inhibitor in vitro
M H Perrone, L T Hamel, R A Ferrari, et al.
Antiviral Therapy
|
February 22, 2000
Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm3
D A Revicki, C Swartz, A W Wu, et al.
Human Gene Therapy
|
July 1, 1995
An open label, phase I/II clinical trial to evaluate the safety and biological activity of HIV-IT (V) (HIV-1IIIBenv/rev retroviral vector) in HIV-1-infected subjects
R Haubrich, J A McCutchan, R Holdredge, et al.
Annals of the New York Academy of Sciences
|
November 27, 1995
Retroviral vectors for HIV immunotherapy
J F Warner, D Jolly, S Mento, et al.
Journal of Medicinal Chemistry
|
February 1, 1982
Aminomethyl-1,2,4-benzothiadiazines as potential analogues of gamma-aminobutyric acid. Unexpected discovery of a taurine antagonist
Y Girard, J G Atkinson, D R Haubrich, et al.
The Western Journal of Medicine
|
August 5, 2000
From the cell to the community: AIDS research in California. The University of California Universitywide AIDS Research Program annual meeting, February 2000
N E Moss, G Lemp, R Bluthenthal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 4, 2011
Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting
G U van Zyl, W Preiser, S Potschka, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1990
In vivo assessment of napamezole, an alpha-2 adrenoceptor antagonist and monoamine re-uptake inhibitor
M H Perrone, D Luttinger, L T Hamel, et al.
Page
of 9